HAVCR2 and breast carcinoma: Interestingly, in contrast with human reports, in FMC, the percentage of tumors having iTILs-TIM-3+ was higher in the luminal A and luminal B mammary carcinoma subtypes (83.3% and 70.6%, respectively) than in the triple-negative basal-like mammary carcinomas (37.5%).